Insights

Strategic Focus Target healthcare facilities and surgical centers where infection control and post-operative outcomes are critical, highlighting PolyPid's localized delivery platform D-PLEX for reducing surgical site infections and potentially cutting SSIs-related costs.

Phase 3 Momentum Leverage recent SHIELD II phase 3 data presentations to engage clinical decision-makers and investors, positioning PolyPid as a late-stage, high-pidelity option for infection prevention at the surgical site.

Key Partnerships Identify opportunities with hospitals, academic medical centers, and government health systems that prioritize antimicrobial resistance management and localized drug delivery to improve patient outcomes and reduce healthcare burden.

Strategic Leadership Utilize updates around board leadership and investor conference participation to build credibility with potential collaborators and highlight long-term governance and strategic growth plans.

Global Exposure Capitalize on international conferences and European regulatory-friendly environments to expand pilot programs or strategic collaborations, particularly in markets with high SSI incidence and strong infection control initiatives.

Similar companies to PolyPid Ltd.

PolyPid Ltd. Tech Stack

PolyPid Ltd. uses 8 technology products and services including Google Fonts API, OWL Carousel, jQuery, and more. Explore PolyPid Ltd.'s tech stack below.

  • Google Fonts API
    Font Scripts
  • OWL Carousel
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Bootstrap
    UI Frameworks
  • GoDaddy
    Web Hosting
  • Acquia Cloud Site Factory
    Web Hosting
  • SiteOrigin Page Builder
    Web Platform Extensions
  • Nginx
    Web Servers

Media & News

PolyPid Ltd.'s Email Address Formats

PolyPid Ltd. uses at least 1 format(s):
PolyPid Ltd. Email FormatsExamplePercentage
First.L@polypid.comJohn.D@polypid.com
92%
FirstL@polypid.comJohnD@polypid.com
5%
FLast@polypid.comJDoe@polypid.com
3%

Frequently Asked Questions

Where is PolyPid Ltd.'s headquarters located?

Minus sign iconPlus sign icon
PolyPid Ltd.'s main headquarters is located at 18 Ha'sivim Petaẖ Tiqwa, Central District Israel. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is PolyPid Ltd.'s stock symbol?

Minus sign iconPlus sign icon
PolyPid Ltd. is a publicly traded company; the company's stock symbol is PYPD.

What is PolyPid Ltd.'s official website and social media links?

Minus sign iconPlus sign icon
PolyPid Ltd.'s official website is polypid.com and has social profiles on LinkedInCrunchbase.

What is PolyPid Ltd.'s SIC code NAICS code?

Minus sign iconPlus sign icon
PolyPid Ltd.'s SIC code is 3841 - Surgical and Medical Instruments and Apparatus NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does PolyPid Ltd. have currently?

Minus sign iconPlus sign icon
As of May 2026, PolyPid Ltd. has approximately 76 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Chief Executive Officer And Board Member: D. C. A.Ceo: A. W.Cfo: S. M.. Explore PolyPid Ltd.'s employee directory with LeadIQ.

What industry does PolyPid Ltd. belong to?

Minus sign iconPlus sign icon
PolyPid Ltd. operates in the Pharmaceutical Manufacturing industry.

What technology does PolyPid Ltd. use?

Minus sign iconPlus sign icon
PolyPid Ltd.'s tech stack includes Google Fonts APIOWL CarouseljQueryBootstrapGoDaddyAcquia Cloud Site FactorySiteOrigin Page BuilderNginx.

What is PolyPid Ltd.'s email format?

Minus sign iconPlus sign icon
PolyPid Ltd.'s email format typically follows the pattern of First.L@polypid.com. Find more PolyPid Ltd. email formats with LeadIQ.

How much funding has PolyPid Ltd. raised to date?

Minus sign iconPlus sign icon
As of May 2026, PolyPid Ltd. has raised $27M in funding. The last funding round occurred on Jun 16, 2025 for $27M.
PolyPid Ltd. logo

PolyPid Ltd.

Pharmaceutical ManufacturingCentral District, Israel51-200 Employees

PolyPid Ltd. is a pharmaceutical company based in Petah Tikva, Israel, operating as a clinical-stage biopharmaceutical firm focused on developing, manufacturing and offering locally administered therapies aimed at improving surgical outcomes. Its core objective is to deliver medications directly to the surgical site to enable controlled, sustained release over multiple days to months, addressing localized conditions such as infection, pain, inflammation and cancer. The company targets surgical patients and healthcare providers looking to reduce surgical site infections and related complications, including those caused by antibiotic-resistant bacteria, thereby reducing healthcare system burdens. Positioned in the pharmaceutical manufacturing and bio-pharma space, PolyPid emphasizes a platform that anchors treatment at the surgical site to support improved outcomes, with a track record of presenting data from Phase 3 studies and engaging with medical and investor audiences. The company operates at a global level and maintains its headquarters in central Israel, with a focus on advancing its late-stage clinical program and pursuing partnerships and communications within the scientific and regulatory communities.

Section iconCompany Overview

Headquarters
18 Ha'sivim Petaẖ Tiqwa, Central District Israel
SIC Code
3841 - Surgical and Medical Instruments and Apparatus
Stock Symbol
PYPD
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
51-200

Section iconFunding & Financials

  • $27M

    PolyPid Ltd. has raised a total of $27M of funding over 10 rounds. Their latest funding round was raised on Jun 16, 2025 in the amount of $27M.

  • $25M$50M

    PolyPid Ltd.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $27M

    PolyPid Ltd. has raised a total of $27M of funding over 10 rounds. Their latest funding round was raised on Jun 16, 2025 in the amount of $27M.

  • $25M$50M

    PolyPid Ltd.'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.